In September 2023, FDA placed "Thymosin Beta-4, Fragment (LKKTETQ)," the substance sold as TB-500, on Category 2 of its interim 503A bulk drug substances list, meaning FDA identified significant safety concerns and would not permit licensed compounding pharmacies to use it
& Hebebrand, J
Regular monitoring and supplementation is recommended
Key Nutrients Found in Weight Loss IV Therapy IV to Lose Weight: How It Works in Practice When people look into IV to lose weight, they often imagine a quick fix
Consult a Professional: If irritation, redness, or breakouts persist or worsen, or if you experience severe reactions like rash, hives, swelling, or difficulty breathing, discontinue use immediately and seek advice from a dermatologist or healthcare expert
Before the cell testing, we analyzed the pH of the samples tested and we excluded the pH of copper compounds as the influencing factor of their potential cytotoxicity (SI 2)